— Know what they know.
Not Investment Advice

HERB OTC

Humanoid Inc
1W: +100.0% 1M: +29.8% 3M: +14.5% YTD: -25.9% 1Y: -32.0% 3Y: -73.6% 5Y: -56.4%
$0.02
+0.00 (+0.00%)
 
OTC · Consumer Defensive · Agricultural Farm Products · Tech Score Neutral · Power 52 · $2.6M mcap · 17M float · 0.035% daily turnover · Short 69% of daily vol

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 54 Grade B
Profitability
53
Balance Sheet
75
Earnings Quality
69
Growth
75
Value
82
Momentum
73
Safety
80
Cash Flow
7
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. HERB scores highest in Value (82/100) and lowest in Cash Flow (7/100). A grade of B indicates above-average fundamentals with room for improvement in select areas.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
3.11
Safe Zone
Piotroski F-Score
7/9
✓ ✓ ✓ ✗ ✗ ✓ ✓ ✓ ✓
Beneish M-Score
-1.54
Possible Manipulator
Ohlson O-Score
-10.98
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
AA
Score: 86.8/100
Trend: Deteriorating
Earnings Quality
25/100
OCF/NI: 0.39x
Accruals: 1.4%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. HERB scores 3.11, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. HERB scores 7/9, signaling strong financial health across all three dimensions. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. HERB's score of -1.54 exceeds the −1.78 red flag threshold — this does not confirm manipulation but indicates the earnings profile resembles past manipulators statistically. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. HERB's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. HERB receives an estimated rating of AA (score: 86.8/100), with a deteriorating trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). HERB's score of 25/100 is low — reported earnings may not be fully supported by cash flows.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
0.32x
PEG
0.01x
P/S
0.11x
P/B
0.01x
P/FCF
-15.53x
P/OCF
5.38x
EV/EBITDA
1.54x
EV/Revenue
0.49x
EV/EBIT
1.65x
EV/FCF
-12.25x
Earnings Yield
47.43%
FCF Yield
-6.44%
Shareholder Yield
0.00%
Graham Number
$1.21
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 0.3x earnings, HERB trades at a deep value multiple. An earnings yield of 47.4% exceeds typical risk-free rates, suggesting equities are being compensated for risk. Graham's intrinsic value formula yields $1.21 per share, suggesting a potential 7313% margin of safety at the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.000
NI / EBT
×
Interest Burden
0.994
EBT / EBIT
×
EBIT Margin
0.299
EBIT / Rev
×
Asset Turnover
0.076
Rev / Assets
×
Equity Multiplier
1.010
Assets / Equity
=
ROE
2.3%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. HERB's ROE of 2.3% is driven by a balanced combination of operating margin, asset efficiency, and leverage. A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
15.00%
Fair P/E
38.50x
Intrinsic Value
$1.48
Price/Value
0.05x
Margin of Safety
94.52%
Premium
-94.52%
Assessment
Undervalued
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with HERB's realized 15.0% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. At an intrinsic value of $1.48, HERB appears undervalued with a 95% margin of safety. The adjusted fair P/E of 38.5x compares to the current market P/E of 0.3x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$0.03
Median 1Y
$0.00
5th Pctile
$0.00
95th Pctile
$0.01
Ann. Volatility
398.3%
25th–75th percentile 5th–95th percentile Median path Historical

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
1,400
0.0% YoY
Revenue / Employee
$670,640
Rev: $938,896,315
Profit / Employee
$79,911
NI: $111,875,965
SGA / Employee
$4,325
Avg labor cost proxy

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'13 Q4'13 Q1'14 Q2'14 Q3'14 Q4'14 Q1'15 Q2'15 Q3'15 Q4'15 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Current
ROE 6.0% 6.3% 6.2% 6.3% 6.3% 6.0% 6.0% 6.0% 5.7% 8.5% 6.8% 4.8% 1.8% 1.6% 1.5% 1.6% 1.9% 2.0% 2.2% 2.3% 2.28%
ROA 5.8% 6.1% 6.0% 6.1% 6.1% 5.9% 5.9% 5.9% 5.6% 8.2% 6.6% 4.7% 1.8% 1.4% 1.5% 1.6% 1.9% 2.0% 2.1% 2.3% 2.26%
ROIC 5.8% 6.0% 6.0% 6.1% 6.0% 5.8% 5.8% 5.8% 5.6% 44.0% 34.9% 24.3% 9.5% 1.3% 1.4% 1.5% 1.9% 1.9% 2.1% 2.2% 2.15%
ROCE 5.7% 6.0% 5.9% 6.0% 5.8% 5.6% 5.6% 5.6% 5.5% 43.5% 34.5% 23.9% 9.0% 1.4% 1.5% 1.6% 2.0% 2.0% 2.2% 2.3% 2.27%
Gross Margin 15.9% 16.4% 11.0% 11.4% 15.3% 17.0% 11.0% 12.2% 16.0% 10.9% 29.6% 28.2% 26.6% 30.8% 31.4% 32.1% 33.4% 22.7% 33.9% 33.7% 33.74%
Operating Margin 15.2% 15.6% 10.3% 10.9% 14.7% 16.5% 10.3% 11.7% 15.3% 10.2% 24.5% 24.9% 22.2% 27.3% 26.6% 28.9% 30.7% 18.8% 29.6% 30.8% 30.76%
Net Margin 15.2% 15.6% 10.1% 11.0% 15.3% 16.3% 10.1% 11.8% 15.3% 9.7% 27.6% 27.4% 25.0% 26.1% 31.9% 30.6% 32.8% 18.6% 33.4% 32.8% 32.80%
EBITDA Margin 15.7% 17.3% 12.0% 12.3% 14.7% 17.5% 11.8% 15.3% 15.3% 12.3% 29.7% 28.8% 26.8% 29.9% 34.0% 30.7% 32.9% 24.2% 35.2% 34.9% 34.89%
FCF Margin 1.5% 0.7% 0.5% 0.4% 0.6% 0.6% 0.6% 0.1% 0.4% -0.4% -1.0% -0.4% -2.1% 13.8% 34.8% 26.2% 9.3% 2.1% 2.8% -4.0% -4.03%
OCF Margin 2.8% 5.1% 5.2% 6.8% 7.0% 11.1% 10.9% 11.2% 11.4% 34.2% 41.7% 57.5% 1.2% 17.4% 36.7% 30.9% 10.9% 12.9% 14.9% 11.6% 11.64%
ROE 3Y Avg snapshot only 9.33%
ROE 5Y Avg snapshot only 7.98%
ROA 3Y Avg snapshot only 9.22%
ROIC 3Y Avg snapshot only 9.10%
ROIC Economic snapshot only 2.11%
Cash ROA snapshot only 0.88%
Cash ROIC snapshot only 0.90%
CROIC snapshot only -0.31%
NOPAT Margin snapshot only 27.83%
Pretax Margin snapshot only 29.72%
R&D / Revenue snapshot only 0.00%
SGA / Revenue snapshot only 3.36%
SBC / Revenue snapshot only 0.00%
Valuation
Metric Trend Q3'13 Q4'13 Q1'14 Q2'14 Q3'14 Q4'14 Q1'15 Q2'15 Q3'15 Q4'15 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Current
P/E Ratio 0.95 0.66 1.31 0.85 0.87 0.72 0.63 0.79 0.59 0.78 0.11 0.17 0.86 3.72 8.43 4.72 3.87 3.06 4.27 2.11 0.318
P/S Ratio 0.12 0.09 0.18 0.11 0.12 0.10 0.09 0.11 0.08 0.09 0.01 0.02 0.09 0.99 2.32 1.35 1.19 0.87 1.24 0.63 0.106
P/B Ratio 0.05 0.04 0.08 0.05 0.05 0.04 0.04 0.05 0.03 0.41 0.04 0.04 0.08 0.05 0.13 0.08 0.08 0.06 0.09 0.05 0.009
P/FCF 8.14 12.30 38.02 27.82 19.16 16.91 15.30 121.15 20.43 -26.42 -1.38 -5.56 -4.38 7.13 6.66 5.16 12.77 40.72 44.58 -15.53 -15.530
P/OCF 4.37 1.76 3.41 1.69 1.67 0.88 0.79 0.98 0.71 0.27 0.03 0.04 0.08 5.67 6.31 4.37 10.85 6.76 8.32 5.38 5.382
EV/EBITDA 0.87 0.60 1.19 0.76 0.78 0.66 0.57 0.70 0.51 1.01 0.11 0.15 0.56 3.06 7.18 3.80 2.94 2.43 3.62 1.54 1.544
EV/Revenue 0.12 0.09 0.18 0.11 0.11 0.09 0.08 0.11 0.08 0.14 0.02 0.02 0.07 0.88 2.13 1.15 0.94 0.74 1.11 0.49 0.494
EV/EBIT 0.95 0.65 1.30 0.83 0.86 0.72 0.62 0.79 0.56 1.17 0.13 0.17 0.70 3.31 7.74 4.02 3.05 2.57 3.82 1.65 1.653
EV/FCF 8.14 12.25 37.83 27.37 18.50 16.34 14.61 116.73 19.43 -39.81 -1.52 -5.40 -3.56 6.35 6.12 4.40 10.09 34.47 40.09 -12.25 -12.250
Earnings Yield 1.1% 1.5% 76.1% 1.2% 1.2% 1.4% 1.6% 1.3% 1.7% 1.3% 8.8% 5.7% 1.2% 26.9% 11.9% 21.2% 25.9% 32.7% 23.4% 47.4% 47.43%
FCF Yield 12.3% 8.1% 2.6% 3.6% 5.2% 5.9% 6.5% 0.8% 4.9% -3.8% -72.5% -18.0% -22.8% 14.0% 15.0% 19.4% 7.8% 2.5% 2.2% -6.4% -6.44%
PEG Ratio snapshot only 0.007
Price/Tangible Book snapshot only 0.093
EV/OCF snapshot only 4.245
EV/Gross Profit snapshot only 1.585
Acquirers Multiple snapshot only 1.776
Shareholder Yield snapshot only 0.00%
Graham Number snapshot only $1.21
Leverage & Solvency
Metric Trend Q3'13 Q4'13 Q1'14 Q2'14 Q3'14 Q4'14 Q1'15 Q2'15 Q3'15 Q4'15 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Current
Current Ratio 11.96 9.96 10.99 11.62 12.34 12.64 13.96 14.55 15.51 1190.09 5.57 3.46 4.31 3.34 7.88 7.27 10.56 2.49 3.95 7.28 7.276
Quick Ratio 3.41 2.70 2.90 3.04 3.09 3.45 4.03 4.13 4.12 1177.50 1.49 2.25 3.76 2.07 6.68 6.87 8.62 1.82 3.35 6.28 6.279
Debt/Equity 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.21 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.009
Net Debt/Equity -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 0.21 0.00 -0.00 -0.01 -0.01 -0.01 -0.01 -0.02 -0.01 -0.01 -0.01 -0.010
Debt/Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.18 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.009
Debt/EBITDA 0.08 0.07 0.07 0.06 0.06 0.06 0.05 0.05 0.05 0.35 0.02 0.04 0.09 0.56 0.44 0.47 0.41 0.30 0.37 0.35 0.354
Net Debt/EBITDA -0.00 -0.00 -0.01 -0.01 -0.03 -0.02 -0.03 -0.03 -0.03 0.34 0.01 -0.00 -0.13 -0.38 -0.64 -0.66 -0.78 -0.44 -0.41 -0.41 -0.413
Interest Coverage 162.13 143.67 142.79 146.12 161.59 116.54 118.05 120.01 119.73 171.84 166118.29 57333.78 14174.51 1582.11 1427.30 1573.58 1855.62 1609.09 1483.25 1299.55 1299.554
Equity Multiplier 1.03 1.03 1.03 1.03 1.03 1.02 1.02 1.02 1.02 1.22 1.01 1.01 1.01 1.01 1.01 1.01 1.01 1.02 1.01 1.01 1.010
Cash Ratio snapshot only 5.234
Debt Service Coverage snapshot only 1391.050
Cash to Debt snapshot only 2.167
FCF to Debt snapshot only -0.356
Defensive Interval snapshot only 3178.5 days
Efficiency & Turnover
Metric Trend Q3'13 Q4'13 Q1'14 Q2'14 Q3'14 Q4'14 Q1'15 Q2'15 Q3'15 Q4'15 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Current
Asset Turnover 0.45 0.45 0.45 0.46 0.45 0.43 0.43 0.43 0.41 0.69 0.53 0.36 0.17 0.05 0.05 0.06 0.06 0.07 0.07 0.08 0.076
Inventory Turnover 3.49 3.18 3.11 2.98 2.81 2.72 2.67 2.57 2.32 4.78 3.70 2.43 1.10 4.73 4.95 9.13 8.47 5.16 14.29 21.81 21.813
Receivables Turnover 10.78 10.38 10.09 10.19 10.45 9.71 9.27 9.04 8.91 16.62 11.95 8.03 3.85 14.96 36.89 26.25 27.31 18.95 33.49 28.80 28.796
Payables Turnover 29.16 30.69 33.98 35.83 36.72 30.46 32.93 33.07 32.30 59.79 50.21 34.26 16.67 51.97 81.02 67.22 53.12 27.46 125.84 138.50 138.497
DSO 34 35 36 36 35 38 39 40 41 22 31 45 95 24 10 14 13 19 11 13 12.7 days
DIO 104 115 117 122 130 134 137 142 157 76 99 150 332 77 74 40 43 71 26 17 16.7 days
DPO 13 12 11 10 10 12 11 11 11 6 7 11 22 7 5 5 7 13 3 3 2.6 days
Cash Conversion Cycle 126 138 143 148 155 160 165 172 187 92 122 185 404 95 79 48 50 77 34 27 26.8 days
Fixed Asset Turnover snapshot only 0.155
Operating Cycle snapshot only 29.4 days
Cash Velocity snapshot only 4.069
Capital Intensity snapshot only 13.197
Growth (YoY)
Metric Trend Q3'13 Q4'13 Q1'14 Q2'14 Q3'14 Q4'14 Q1'15 Q2'15 Q3'15 Q4'15 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Current
Revenue 0.1% 1.8% 2.1% 5.0% 7.6% 3.2% 2.9% -0.0% -4.8% -10.1% -30.0% -51.7% -76.3% -98.5% -98.0% -97.0% -92.8% 32.6% 35.7% 34.6% 34.62%
Net Income 4.5% 8.0% 8.2% 10.6% 12.1% 4.2% 3.9% 2.9% -2.8% -21.3% -35.8% -54.6% -82.0% -96.7% -95.6% -93.4% -78.9% 42.8% 43.5% 40.0% 40.02%
EPS 4.5% 8.0% 8.2% 10.6% 12.1% -5.3% 3.9% 2.9% -4.1% -22.4% -42.4% -59.3% -83.6% -96.7% -95.6% -92.8% -76.8% 57.1% 57.8% 40.0% 40.02%
FCF -45.0% -78.5% -76.0% -78.1% -56.6% -17.2% 24.2% -77.9% -37.8% -1.5% -2.3% -3.2% -2.2% 1.6% 1.7% 2.9% 1.3% -79.5% -89.1% -1.2% -1.21%
EBITDA 4.2% 8.6% 8.0% 10.1% 10.5% 0.6% 0.1% 2.5% 0.6% -14.1% -30.0% -54.6% -79.7% -96.9% -95.9% -93.6% -82.5% 40.4% 41.2% 42.4% 42.42%
Op. Income 4.1% 8.0% 8.2% 11.0% 10.8% 3.3% 2.9% 1.9% -1.3% -19.9% -34.8% -53.8% -81.5% -96.9% -96.1% -94.0% -80.9% 43.0% 47.3% 41.6% 41.62%
OCF Growth snapshot only -49.24%
Asset Growth snapshot only 0.38%
Equity Growth snapshot only 0.33%
Debt Growth snapshot only 7.51%
Shares Change snapshot only 0.00%
Growth (CAGR)
Metric Trend Q3'13 Q4'13 Q1'14 Q2'14 Q3'14 Q4'14 Q1'15 Q2'15 Q3'15 Q4'15 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Current
Revenue 3Y 32.3% 14.1% 5.0% 6.6% 5.4% 3.2% 2.9% 2.8% 0.8% -1.9% -9.7% -20.3% -37.6% -76.0% -75.8% -75.7% -74.7% -73.9% -73.4% -73.1% -73.14%
Revenue 5Y — — — — — — — 40.5% 18.9% 6.6% -3.6% -10.2% -23.4% -57.0% -56.8% -56.5% -55.5% -54.9% -54.4% -54.1% -54.11%
EPS 3Y 35.4% 18.5% 10.4% 11.7% 10.1% 4.2% 7.3% 7.3% 4.0% -7.4% -13.5% -22.6% -43.9% -71.0% -70.4% -68.8% -66.8% -65.7% -65.9% -65.4% -65.45%
EPS 5Y — — — — — — — 48.8% 21.7% 4.1% -4.3% -10.2% -26.8% -50.7% -50.1% -48.5% -46.8% -47.1% -46.3% -45.8% -45.77%
Net Income 3Y 35.4% 18.5% 10.4% 11.7% 10.1% 7.6% 7.3% 7.3% 4.4% -4.0% -10.3% -19.8% -41.9% -69.9% -69.3% -68.7% -66.7% -66.6% -65.8% -65.3% -65.30%
Net Income 5Y — — — — — — — 48.8% 22.0% 6.4% -2.2% -8.3% -25.2% -49.6% -49.0% -48.3% -46.6% -47.0% -46.2% -45.6% -45.62%
EBITDA 3Y 35.1% 18.6% 10.2% 11.3% 9.1% 6.5% 6.2% 7.2% 5.0% -2.1% -8.9% -20.0% -39.1% -70.1% -69.5% -69.1% -67.1% -66.6% -65.8% -65.5% -65.47%
EBITDA 5Y — — — — — — — 48.7% 22.3% 7.6% -1.2% -8.5% -23.3% -49.7% -49.1% -48.7% -47.2% -47.3% -46.6% -45.9% -45.88%
Gross Profit 3Y 34.8% 18.0% 9.8% 11.1% 9.1% 6.6% 6.3% 6.3% 4.2% -3.6% -10.1% -19.3% -40.7% -69.6% -69.2% -68.6% -66.6% -66.4% -65.5% -65.1% -65.13%
Gross Profit 5Y — — — — — — — 47.9% 21.6% 6.4% -2.3% -8.2% -24.5% -49.5% -49.1% -48.3% -46.7% -47.0% -46.2% -45.6% -45.64%
Op. Income 3Y 34.6% 17.9% 9.8% 11.2% 9.1% 6.9% 6.6% 6.6% 4.4% -3.7% -10.1% -19.5% -41.3% -70.6% -70.2% -69.5% -67.3% -67.3% -66.4% -66.0% -65.98%
Op. Income 5Y — — — — — — — 48.3% 21.7% 6.3% -2.3% -8.3% -25.0% -50.4% -50.0% -49.2% -47.4% -47.7% -46.9% -46.3% -46.33%
FCF 3Y 39.0% 4.9% -19.1% -23.1% -8.0% -10.3% -38.1% -66.8% -47.0% — — — — -35.8% 2.1% -2.8% -37.3% -59.6% -54.7% — —
FCF 5Y — — — — — — — 21.0% -6.2% — — — — -25.4% -27.3% -31.4% -43.2% -58.9% -51.2% — —
OCF 3Y 4.2% 7.9% -4.6% 1.5% -3.1% 10.5% 10.3% 19.7% 35.1% 1.1% 1.2% 1.4% 1.2% -63.7% -53.5% -59.6% -70.6% -72.6% -70.5% -72.8% -72.79%
OCF 5Y — — — — — — — 59.0% 36.2% 51.2% 38.1% 33.9% 28.1% -51.0% -42.5% -41.6% -47.4% -41.2% -37.1% -35.9% -35.85%
Assets 3Y 7.7% 8.0% 7.5% 7.1% 6.4% 6.4% 6.3% 6.7% 6.7% -50.7% -50.5% -50.2% -50.3% -51.7% -51.6% -51.8% -51.9% -52.3% -52.5% -52.7% -52.67%
Assets 5Y — — — — — — — 7.2% 7.1% -32.7% -32.6% -32.3% -32.6% -33.6% -33.6% -33.7% -33.7% -34.1% -34.3% -34.5% -34.53%
Equity 3Y 9.1% 9.1% 8.5% 8.0% 7.3% 7.3% 7.1% 7.5% 7.4% -53.3% -50.1% -49.9% -50.1% -51.4% -51.3% -51.5% -51.6% -52.2% -52.4% -52.5% -52.48%
Book Value 3Y 9.1% 9.1% 8.5% 8.0% 7.3% 4.0% 7.1% 7.5% 6.9% -54.9% -51.9% -51.7% -51.9% -53.1% -53.0% -51.7% -51.8% -50.9% -52.6% -52.7% -52.69%
Dividend 3Y — — — — — — — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q3'13 Q4'13 Q1'14 Q2'14 Q3'14 Q4'14 Q1'15 Q2'15 Q3'15 Q4'15 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Current
Revenue Stability 0.71 0.75 0.91 0.94 0.90 0.98 0.99 0.74 0.71 0.53 0.03 0.13 0.27 0.39 0.51 0.60 0.65 0.67 0.75 0.80 0.803
Earnings Stability 0.81 0.92 1.00 0.79 0.83 0.89 0.98 0.76 0.76 0.36 0.01 0.02 0.18 0.38 0.46 0.53 0.60 0.72 0.77 0.80 0.796
Margin Stability 0.97 0.95 0.94 0.95 0.96 0.95 0.95 0.90 0.95 0.95 0.95 0.95 0.92 0.59 0.58 0.57 0.50 0.56 0.56 0.55 0.549
Rev. Growth Consistency 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.500
Earn. Growth Consistency 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.500
FCF Positive Streak 1 1 1 1 1 1 1 1 1 0 0 0 0 0 0 0 0 1 1 0 0
Earnings Persistence 0.98 0.97 0.97 0.96 0.95 0.98 0.98 0.99 0.99 0.91 0.86 0.50 0.50 0.50 0.50 0.50 0.50 0.83 0.83 0.84 0.840
Earnings Smoothness 0.96 0.92 0.92 0.90 0.89 0.96 0.96 0.97 0.97 0.76 0.56 0.25 0.00 0.00 0.00 0.00 0.00 0.65 0.64 0.67 0.667
ROE Trend -0.00 0.00 0.00 0.00 0.00 -0.00 -0.00 -0.00 -0.00 0.47 0.29 0.18 0.03 -0.28 -0.19 -0.13 -0.05 -0.25 -0.16 -0.11 -0.106
Gross Margin Trend 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.01 0.01 -0.01 -0.01 -0.00 -0.02 0.15 0.15 0.16 0.19 0.09 0.10 0.09 0.091
FCF Margin Trend -0.00 -0.01 -0.02 -0.02 -0.02 -0.01 -0.01 -0.01 -0.01 -0.01 -0.02 -0.01 -0.03 0.14 0.35 0.26 0.10 -0.05 -0.14 -0.17 -0.169
Sustainable Growth Rate 6.0% 6.3% 6.2% 6.3% 6.3% 6.0% 6.0% 6.0% 5.7% 8.5% 6.8% 4.8% 1.8% 1.6% 1.5% 1.6% 1.9% 2.0% 2.2% 2.3% 2.28%
Internal Growth Rate 6.2% 6.4% 6.4% 6.5% 6.5% 6.3% 6.2% 6.3% 5.9% 8.9% 7.1% 4.9% 1.8% 1.4% 1.5% 1.6% 2.0% 2.0% 2.2% 2.3% 2.31%
Cash Flow Quality
Metric Trend Q3'13 Q4'13 Q1'14 Q2'14 Q3'14 Q4'14 Q1'15 Q2'15 Q3'15 Q4'15 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Current
OCF/Net Income 0.22 0.37 0.39 0.50 0.52 0.82 0.80 0.81 0.83 2.87 3.34 4.44 11.23 0.66 1.34 1.08 0.36 0.45 0.51 0.39 0.392
FCF/OCF 0.54 0.14 0.09 0.06 0.09 0.05 0.05 0.01 0.03 -0.01 -0.02 -0.01 -0.02 0.79 0.95 0.85 0.85 0.17 0.19 -0.35 -0.347
FCF/Net Income snapshot only -0.136
OCF/EBITDA snapshot only 0.364
CapEx/Revenue 1.3% 4.3% 4.7% 6.3% 6.4% 10.5% 10.4% 11.1% 11.0% 34.5% 42.7% 57.9% 1.2% 3.6% 2.0% 4.7% 1.6% 10.8% 12.1% 15.7% 15.68%
CapEx/Depreciation snapshot only 7.446
Accruals Ratio 0.05 0.04 0.04 0.03 0.03 0.01 0.01 0.01 0.01 -0.15 -0.16 -0.16 -0.18 0.00 -0.01 -0.00 0.01 0.01 0.01 0.01 0.014
Sloan Accruals snapshot only 0.002
Cash Flow Adequacy snapshot only 0.743
Earnings Quality Score snapshot only 0.250
Dividends & Buybacks
Metric Trend Q3'13 Q4'13 Q1'14 Q2'14 Q3'14 Q4'14 Q1'15 Q2'15 Q3'15 Q4'15 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
FCF Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% — — — — 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% — —
Total Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Div. Increase Streak — — — — — — — — — — — — — — — — — — — — —
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -2.4% -19.9% -18.1% -9.6% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Total Shareholder Return 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -2.4% -19.9% -18.1% -9.6% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
DuPont Factors
Metric Trend Q3'13 Q4'13 Q1'14 Q2'14 Q3'14 Q4'14 Q1'15 Q2'15 Q3'15 Q4'15 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Current
Tax Burden (NI/EBT) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Interest Burden (EBT/EBIT) 0.99 0.99 0.99 1.00 1.03 1.03 1.03 1.03 0.99 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.99 0.99 0.99 0.994
EBIT Margin 0.13 0.14 0.14 0.13 0.13 0.13 0.13 0.13 0.14 0.12 0.12 0.13 0.10 0.27 0.27 0.29 0.31 0.29 0.29 0.30 0.299
Asset Turnover 0.45 0.45 0.45 0.46 0.45 0.43 0.43 0.43 0.41 0.69 0.53 0.36 0.17 0.05 0.05 0.06 0.06 0.07 0.07 0.08 0.076
Equity Multiplier 1.03 1.03 1.03 1.03 1.03 1.03 1.02 1.02 1.02 1.04 1.02 1.02 1.02 1.10 1.01 1.01 1.01 1.02 1.01 1.01 1.010
Per Share
Metric Trend Q3'13 Q4'13 Q1'14 Q2'14 Q3'14 Q4'14 Q1'15 Q2'15 Q3'15 Q4'15 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Current
EPS (Diluted TTM) $0.82 $0.88 $0.88 $0.91 $0.92 $0.83 $0.92 $0.93 $0.89 $0.65 $0.53 $0.38 $0.15 $0.02 $0.02 $0.03 $0.03 $0.03 $0.04 $0.04 $0.04
Book Value/Share $14.29 $14.72 $14.79 $14.95 $15.23 $14.20 $15.71 $15.95 $15.97 $1.23 $1.52 $1.58 $1.59 $1.51 $1.53 $1.68 $1.70 $1.68 $1.67 $1.69 $1.81
Tangible Book/Share $7.53 $7.90 $8.04 $8.24 $8.44 $7.76 $8.66 $8.87 $8.85 $0.65 $1.52 $1.58 $1.59 $0.80 $1.53 $1.68 $1.70 $0.90 $1.67 $0.87 $0.87
Revenue/Share $6.38 $6.52 $6.55 $6.76 $6.86 $6.12 $6.74 $6.76 $6.45 $5.43 $4.23 $2.93 $1.39 $0.08 $0.08 $0.10 $0.11 $0.12 $0.13 $0.13 $0.15
FCF/Share $0.10 $0.05 $0.03 $0.03 $0.04 $0.04 $0.04 $0.01 $0.03 $-0.02 $-0.04 $-0.01 $-0.03 $0.01 $0.03 $0.03 $0.01 $0.00 $0.00 $-0.01 $0.02
OCF/Share $0.18 $0.33 $0.34 $0.46 $0.48 $0.68 $0.74 $0.76 $0.74 $1.86 $1.76 $1.68 $1.63 $0.01 $0.03 $0.03 $0.01 $0.02 $0.02 $0.02 $0.03
Cash/Share $0.07 $0.07 $0.07 $0.07 $0.09 $0.07 $0.08 $0.08 $0.07 $0.01 $0.00 $0.02 $0.04 $0.02 $0.03 $0.03 $0.04 $0.03 $0.03 $0.03 $0.05
EBITDA/Share $0.90 $0.97 $0.97 $0.99 $0.99 $0.88 $0.97 $1.02 $0.98 $0.75 $0.61 $0.42 $0.18 $0.02 $0.02 $0.03 $0.03 $0.04 $0.04 $0.04 $0.04
Debt/Share $0.07 $0.07 $0.07 $0.06 $0.06 $0.05 $0.05 $0.05 $0.05 $0.26 $0.01 $0.01 $0.02 $0.01 $0.01 $0.01 $0.01 $0.01 $0.01 $0.01 $0.01
Net Debt/Share $-0.00 $-0.00 $-0.01 $-0.01 $-0.03 $-0.02 $-0.03 $-0.03 $-0.03 $0.26 $0.01 $-0.00 $-0.02 $-0.01 $-0.02 $-0.02 $-0.03 $-0.02 $-0.02 $-0.02 $-0.02
Academic Models
Metric Trend Q3'13 Q4'13 Q1'14 Q2'14 Q3'14 Q4'14 Q1'15 Q2'15 Q3'15 Q4'15 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — 3.113
Altman Z-Prime snapshot only 5.446
Piotroski F-Score 7 7 7 7 7 7 7 6 5 6 6 4 4 5 6 7 6 6 6 7 7
Beneish M-Score -2.13 -2.25 -2.27 -2.25 -2.29 -2.30 -2.25 -2.28 -2.23 -8.83 -12.02 -11.79 -11.94 -4.55 -2.38 -2.81 -2.54 -2.17 -1.86 -1.54 -1.541
Ohlson O-Score snapshot only -10.975
ROIC (Greenblatt) snapshot only 4.42%
Net-Net WC snapshot only $0.03
EVA snapshot only $-20626235.30
Credit
Metric Trend Q3'13 Q4'13 Q1'14 Q2'14 Q3'14 Q4'14 Q1'15 Q2'15 Q3'15 Q4'15 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Current
Credit Rating snapshot only AA
Credit Score 90.04 85.97 95.75 92.04 89.50 85.40 85.11 89.52 84.96 91.77 91.55 93.32 93.39 86.15 96.62 96.68 96.86 79.40 98.71 86.83 86.829
Credit Grade snapshot only 3
Credit Trend snapshot only -9.853
Implied Spread (bps) snapshot only 80.000
Industry Credit Rank snapshot only 85
Sector Credit Rank snapshot only 77

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms